Clinical Trial Compliance & Operations Tech, IRT, RBQM, RTSM

CLINICAL TRIAL COMPLIANCE & OPERATIONS TECHNOLOGY INSIGHTS

The FDA's RTCT Push: What It Is; Why It Matters
The FDA launched real-time clinical trials with AstraZeneca and Amgen. Here’s what RTCT is, why it matters, and what it actually demands from the clinical research ecosystem.
Pharma's Digital Transformation: Where It's Really At
Culture is still pharma’s biggest transformation bottleneck – what does it take to move from project thinking to product thinking?

The Pendulum Of RTSM Configuration Vs. Customization

As technology continues to evolve, learn how IRT systems can no longer be implemented into the fabric of the organization, but rather need to ebb and flow with the needs of clinical trials.
Improving Supply Chain: Accountability, Sustainability, Optimization

Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.
Evolving IRT For Today's Trials: Flexibility, Site Experience, And Integrated Workflow

Interactive Response Technology is evolving beyond traditional randomization and trial supply management to help guide protocol workflows in increasingly complex studies.

Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call

Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
Using Risk-Based Monitoring To Focus On Timelines, Quality, And Budget

Tanya du Plessis, VP of Data Solutions and Strategies at Bioforum, and Rich Davies, VP of Solutions Expert at CluePoints, explain the principle applications of RBQM to Data Management.
Repositioning Your CDM Team To Meet Digital Trial Demands

Consider these steps when repositioning your clinical data management team to unify cross-functional reviews and align processes and technology to meet the demands of digital trials.

Human-Centered RTSM Design Enhances Data, Safety, And Operations

Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.
The Pendulum Of RTSM Configuration Vs. Customization

As technology continues to evolve, learn how IRT systems can no longer be implemented into the fabric of the organization, but rather need to ebb and flow with the needs of clinical trials.
Supporting Early Phase Oncology Research With The Right Data Management System

Better understand how the evolving landscape drives innovation, why your data capture strategy needs the right technology foundation, and what to look for in a CDMS/EDC system for early-phase oncology.

US Healthcare System Overview

A clear guide to U.S. coverage, regulation, and reimbursement: who decides care, how products gain access, and how policy and financing shape cost, value, and patient access.
How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3

Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).
5 Trends To Watch This Year

Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.

The Rise Of The Clinical Trial Site Mega Network

Learn about the evolving U.S. clinical trial site market landscape including a detailed analysis of ownership models, market segmentation, and the role of financial investors in acquisitions.
Helping Biotechs Overcome 4 Key Challenges

Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.
When Sites Don't Get Paid

Discover how Greenphire's innovative payment solutions can transform your clinical trial operations and ensure site sustainability.

Automation Is Not Just AI

Hassan Khalid of AstraZeneca and Jessica Jolly, a senior data and science executive, talk about the advantages of automation as a result of a Guidance like ICH M11, and why “automation” is not synonymous with AI in this case.
Can CDOs and CDAOs Evolve From Monotonous SOPs & Reg Filings?

Jessica Jolly, a senior data and science executive, is challenging CDOs (chief data officers) and CDAOs (chief data & analytics officers) to stop putting the data science community “to sleep” with the traditional monotonous SOPs, and instead, move more toward autonomous governance by design.
The Most Adopted eISF For Faster Clinical Trials

Modernize your study binder processes with Florence eBinders™, offering remote access for sponsor interactions, monitoring, and source data review.

Transforming Clinical Trial Site Forecasting

In today’s ever-evolving clinical trial space, managing the expenses associated with conducting a study is more important – and fraught – than ever before.
Unified Technology To Streamline Clinical Trials

Connect every step of the trial journey with patented data-level integration that links sponsors, sites, and patients.
Greenphire Clinical Finance Suite: Site Payments

Automate and simplify complex global investigator payments with a proven solution used across 80+ countries.